hotspot -WSS

hotspot

author：comprehensive 2025-10-01 17:19:47 - browse：34956

When is a billion-dollar deal a bad omen? Has Wall Street gone overboard on Ozempic? And how do you edit a chicken?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss Bristol Myers Squibb’s multibillion-dollar acquisition of Mirati Therapeutics and what it means for a biotech sector still in a slump. We also explain the latest news in the life sciences, including Wall Street’s freakout over GLP-1, CRISPR’ing animals, and the latest in the NASH saga.

For more on what we cover, here’s the news on Mirati; here’s more on biotech venture capital; here’s the latest on Alnylam Pharmaceuticals; here’s more on NASH; here’s the story on xenotransplantation; here’s more on genome-edited chickens; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： DeSantis talks Trump, trans issues and 'what wokeness is'

WSS

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Divers poised to search for children washed away in Pennsylvania flash flood

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Why Congress must ban federal programs from using QALYs

Scrutiny of post

Liver decline slowed by off

hotspot

hotspot

explore

Drug repurposing or repositioning? The language matters

Listen: More tumult at BIO & coercive care for sickle cell patients

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

I learned firsthand about improving diversity in clinical trials

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Liver decline slowed by off

Affirmative action in medical school literally saved lives

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Virginia high school admissions case could be legal follow

As a primary care physician, here's how I hope to partner with AI

explore

Questions and answers about ramping up H5N1 bird flu vaccine

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Investigation reveals sickle cell patients pressured into sterilizations

Biogen joins immunology wave with $1.15 billion acquisition of HI

Questions and answers about ramping up H5N1 bird flu vaccine

Wikipedia

Wikipedia

knowledge

focus